Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats.


INTRODUCTION AND AIMS Elevated plasma free fatty acid (FFA) concentrations play a role in the pathogenesis of type 2 diabetes (2DM). Antilipolytic agents that reduce FFA concentrations may be potentially useful in the treatment of 2DM. Our previous observation that CVT-3619 lowered plasma FFA and triglyceride concentrations in rats and enhanced insulin… (More)
DOI: 10.1111/j.1463-1326.2008.00902.x

6 Figures and Tables


  • Presentations referencing similar topics